Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-000099

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Jan 20, 2017
Accepted (ET)
Jan 25, 2017 · 5:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Jan 20, 2017L124$6.51A80,057IBy: Separately Managed Account
Common StockF1,F5Jan 23, 2017P2,130$6.51A82,187IBy: Separately Managed Account
Common StockF1,F6,F7Jan 24, 2017M20,227—A20,227D
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF2holding———363,611IBy: Lone Star Value Investors, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF6,F7—Jan 24, 2017M20,227A——Common Stock20,2270D

Explanation of responses